KanonCure Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
1
- Latest Deal Type
-
2ndary - Private
KanonCure General Information
Description
Developer of a personalized cancer treatment platform designed to provide patients with effective treatment for their specific cancer. The company's platform specializes in cell therapy research and drug discovery, bringing products related to the treatment, diagnosis, and prevention of severe liver disease, enabling patients to get effective and safe treatment methods by reducing the fibrous component of cirrhosis and promoting liver regeneration.
Contact Information
Website
www.kanoncure.comCorporate Office
- 86 Nishimachi
- Tottori University Faculty of Medicine
- Yonago, Tottori 683-8503
- Japan
Corporate Office
- 86 Nishimachi
- Tottori University Faculty of Medicine
- Yonago, Tottori 683-8503
- Japan
KanonCure Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 1. Seed Round | 25-Jul-2018 | Completed | Generating Revenue |
KanonCure Patents
KanonCure Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3805383-A1 | Fibrosis-inhibiting composition, cells producing same, and cell sheet comprising said cells | Inactive | 08-Jun-2018 | ||
| EP-3805383-A4 | Fibrosis-inhibiting composition, cells producing same, and cell sheet comprising said cells | Inactive | 08-Jun-2018 | ||
| US-11866483-B2 | Fibrosis-inhibiting composition, cells producing same, and cell sheet comprising said cells | Active | 08-Jun-2018 | ||
| US-20210115112-A1 | Fibrosis-inhibiting composition, cells producing same, and cell sheet comprising said cells | Active | 08-Jun-2018 | ||
| WO-2019235362-A1 | Fibrosis-inhibiting composition, cells producing same, and cell sheet comprising said cells | Inactive | 08-Jun-2018 | C07K14/8146 |
KanonCure Signals
KanonCure FAQs
-
When was KanonCure founded?
KanonCure was founded in 2016.
-
Where is KanonCure headquartered?
KanonCure is headquartered in Yonago, Japan.
-
What is the size of KanonCure?
KanonCure has 1 total employees.
-
What industry is KanonCure in?
KanonCure’s primary industry is Drug Discovery.
-
Is KanonCure a private or public company?
KanonCure is a Private company.
-
What is KanonCure’s current revenue?
The current revenue for KanonCure is .
-
How much funding has KanonCure raised over time?
KanonCure has raised $6.15M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process